NSEGeneral Updates5d ago · 4 Nov 2026, 06:38 pm

General Updates

Gufic Biosciences Limited · GUFICBIO

✦ AI SummaryRegulatory

Gufic Biosciences Limited has received an order from the Income Tax Appellate Tribunal (ITAT) regarding the assessment under Section 143(3) read with Section 144B of the Income Tax Act, 1961, for the Assessment Year 2023-24. The order allows the Income Tax Department's appeal and the Company's cross-objection for statistical purposes, setting aside the findings of the Commissioner of Income Tax (Appeals) and restoring the matters to the file of the Assessing Officer for fresh consideration.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gufic Biosciences Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

GUFIC_04112026183618_finalintimation.pdf

pdf

Download →
View document text
338/LG/SE/NOV/2026/GBSL November 04, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code : 509079 Scrip Symbol : GUFICBIO Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In continuation of our earlier intimations dated March 19, 2025, April 14, 2025 and April 03, 2026 and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), this is to inform that the Company has, on November 04, 2026, received an order dated October 15, 2026, passed by the Hon’ble Income Tax Appellate Tribunal (ITAT), Mumbai, in respect of the assessment under Section 143(3) read with Section 144B of the Income Tax Act, 1961 (“the Act”) for the Assessment Year 2023-24. Pursuant to the Assessment Order dated March 18, 2025, a tax demand of Rs. 11,88,88,580/- was raised against the Company, which was subsequently reduced to Rs. 11,76,198/- by the Commissioner of Income Tax (Appeals) [“CIT(A)”]. The Income Tax Department filed an appeal before the ITAT against the relief granted by the CIT(A), while the Company filed a cross-objection against the disallowance sustained by the CIT(A). By the aforesaid order, the ITAT has allowed both the Department’s appeal and the Company’s cross- objection for statistical purposes, set aside the findings of the CIT(A), and restored the matters to the file of the Assessing Officer for fresh consideration in accordance with law. The tax liability, if any, will be determined upon completion of the fresh assessment proceedings. The details required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 issued thereunder are as below: Particulars Details 1. Name of the Authority Income Tax Appellate Tribunal, Mumbai 2. Nature and details of the action(s) Order dated October 15, 2026, bearing ITA No. taken, initiated or order(s) passed 7885/MUM/2025 and CO No. 30/MUM/2026 for Assessment Year 2023-24, whereby the appeal filed by the Income Tax Department and the cross- objection filed by the Company have been allowed for statistical purposes. 3. Date of receipt of direction or Order dated October 15, 2026, received by the order, including any ad-interim or Company on November 04, 2026. interim orders, or any other communication from the authority 4. Details of the violation(s) or The matter relates to certain disallowances made contravention(s) committed or during the assessment proceedings for Assessment alleged to be committed. Year 2023-24. 5. Impact on financial, operation or No demand arises from the said order and there is no other activities of the listed entity, impact on the operations of the Company. The tax quantifiable in monetary terms to liability, if any, will be determined upon completion the extent possible. of the fresh assessment proceedings. The Company will take appropriate steps to protect its interests. Kindly take the same on your record. Thanking You, Yours truly, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No. A39579